Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cerecor Inc. (NASDAQ: CERC).

Full DD Report for CERC

You must become a subscriber to view this report.


Recent News from (NASDAQ: CERC)

BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
$50 Million Equity Financing Led By Broadfin Announced Separately Today Three New Independent Directors Selected by Broadfin Added To Board; Four Current Independent Directors Retiring Amends Senior Credit Facility with CRG, which Includes Pushing Out Principal Debt Repayment...
Source: GlobeNewswire
Date: May, 17 2018 08:01
Cerecor Reports First Quarter 2018 Financial Results
BALTIMORE, May 11, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC) (“Cerecor” or the “Company”) today announced financial results for the first quarter of 2018. Net revenues for the first quarter of 2018 were $4.5 million.  As of March 31, 2018, the Comp...
Source: GlobeNewswire
Date: May, 11 2018 08:15
Wired News - CymaBay Therapeutics Starts Phase-2b Clinical Trials of Seladelpar for Treatment of Patients with Non-Alcoholic Steatohepatitis
Stock Monitor: Cerecor Post Earnings Reporting LONDON, UK / ACCESSWIRE / May 10, 2018 / If you want access to our free research report on CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), all you need to do is sign up now by clicking the following link www.active-investors.com/registration...
Source: ACCESSWIRE IA
Date: May, 10 2018 07:40
Daily Insider Ratings Round Up 4/18/18: APO, CERC, HCAP
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: April, 20 2018 00:16
Cerecor Appoints Simon Pedder to its Board of Directors
BALTIMORE, MD --(Marketwired - April 09, 2018) - Cerecor, Inc. (NASDAQ: CERC) , today announced that Simon C. Pedder, Ph.D. has been appointed to its Board of Directors. "We are delighted to welcome Dr. Pedder to our Board." said Dr. Uli Hacksell, Chairman of the Board of Cerecor, "With...
Source: Marketwired
Date: April, 09 2018 08:00
Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017
BALTIMORE, MD --(Marketwired - April 02, 2018) - Cerecor Inc. (NASDAQ: CERC) today announced financial results for the fourth quarter and full year 2017. Net Revenues for the year ended 2017 were $27.8 million. As of December 31, 2017, the Company had $43.1 million in total assets inclu...
Source: Marketwired
Date: April, 02 2018 08:00
Cerecor appoints Peter Greenleaf as CEO
Cerecor (NASDAQ: CERC ) appoints Peter Greenleaf as CEO. Prior to joining, he has most recently served as Chairman and CEO of Sucampo Pharmaceuticals. More news on: Cerecor, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: March, 28 2018 08:56
Cerecor Appoints Peter Greenleaf as Chief Executive Officer
BALTIMORE, MD --(Marketwired - March 28, 2018) - Cerecor, Inc. (NASDAQ: CERC) today announced that its Board of Directors has appointed Peter Greenleaf as Chief Executive Officer. Mr. Greenleaf has served on the Company's board since May 2017. He brings to Cerecor over two decades of bi...
Source: Marketwired
Date: March, 28 2018 08:00
Your Daily Pharma Scoop: Akebia Update, Rexahn Data, Concert Commences Enrollment
Analysis of top Seeking Alpha coverage: Akebia Today we will focus on Akebia Therapeutics ( AKBA ) after the company provided an update to investors on its late-stage vadadustat studies. Vadadustat is AKBA’s lead product candidate being evaluated for the treatment of anemia assoc...
Source: SeekingAlpha
Date: February, 14 2018 08:00
Cerecor to acquire Avadel Pharmaceutical's pediatric assets
Cerecor ( CERC +8.5% ) has entered into definitive agreements with Avadel U.S. Holdings, Inc., and its subsidiaries, to purchase and acquire all rights to Avadel's marketed pediatric products. More news on: Cerecor, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: February, 12 2018 14:19

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-173.953.88654.003.850154,524
2018-08-164.093.954.123.8660,849
2018-08-154.074.014.083.980125,564
2018-08-144.004.054.1944.0034,523
2018-08-134.484.144.484.1457,618

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-172,66612,30221.6713Cover
2018-08-167,80227,52828.3421Cover
2018-08-151,07910,8539.9420Cover
2018-08-143,84311,74832.7120Cover
2018-08-139,28528,86032.1726Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CERC.


About Cerecor Inc. (NASDAQ: CERC)

Logo for Cerecor Inc. (NASDAQ: CERC)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $116,418,976 - 05/15/2018
  • Issue and Outstanding: 31,379,778 - 03/16/2018

 


Recent Filings from (NASDAQ: CERC)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 11 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 11 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 18 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 05 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 05 2018

 

 


Daily Technical Chart for (NASDAQ: CERC)

Daily Technical Chart for (NASDAQ: CERC)


Stay tuned for daily updates and more on (NASDAQ: CERC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CERC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CERC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CERC and does not buy, sell, or trade any shares of CERC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/